Free Trial
OTCMKTS:ATMS

Artemis Therapeutics (ATMS) Stock Price, News & Analysis

Artemis Therapeutics logo

About Artemis Therapeutics Stock (OTCMKTS:ATMS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
2,942 shs
Market Capitalization
$55.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Artemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.

Receive ATMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artemis Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATMS Stock News Headlines

The Impact Of Utility ATMs On Financial Access
The Man I Turn to In Times Like This
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.
ITRM Iterum Therapeutics plc
See More Headlines

ATMS Stock Analysis - Frequently Asked Questions

Shares of ATMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Artemis Therapeutics investors own include SiteOne Landscape Supply (SITE), Nabriva Therapeutics (NBRV), Meta Platforms (META), Gemini Therapeutics (GMTX), ERYTECH Pharma (ERYP) and Bruush Oral Care (BRSH).

Company Calendar

Today
5/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Miscellaneous chemical products
Sub-Industry
Consumer Goods
Current Symbol
OTCMKTS:ATMS
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,360,000.00
Net Margins
-299.54%
Pretax Margin
-299.54%

Debt

Sales & Book Value

Annual Sales
$310,000.00
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
N/A

Miscellaneous

Free Float
103,687,000
Market Cap
$55.79 million
Optionable
Not Optionable
Beta
-1.92
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:ATMS) was last updated on 5/9/2025 by MarketBeat.com Staff
From Our Partners